Cargando…

Fulminant hepatitis

In conclusion, evidence exists that cellular and humoral immune-mediated processes result in hepatic necrosis in FH. Activation of the immune coagulation system appears to be an integral part of the inflammatory process resulting in fibrin thrombi which have been demonstrated in the liver, kidneys a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sinclair, Stephen, Wakefield, Andrew, Levy, Gary
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer-Verlag 1990
Materias:	HBV-induced Liver Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087515/ https://www.ncbi.nlm.nih.gov/pubmed/1695027 http://dx.doi.org/10.1007/BF00192680

Ejemplares similares

Significance of detectable hepatitis B virus DNA in liver allograft tissue in long-term follow-up of liver transplant recipients
por: Mut Surmeli, Deniz, et al.
Publicado: (2021)

Hepatitis B in pregnancy
por: Dyson, Jessica Katharine, et al.
Publicado: (2014)

Interferon and Interferon Inducers in the Treatment of Malignancies
por: Levy, Hilton B., et al.
Publicado: (1970)

Switching to tenofovir alafenamide for nucleos(t)ide analogue‐experienced patients with chronic hepatitis B: week 144 results from a real‐world, multi‐centre cohort study
por: Ogawa, Eiichi, et al.
Publicado: (2022)

Provision and standards of care for treatment and follow-up of patients with Autoimmune Hepatitis (AIH)
por: Gordon, Victoria Mary, et al.
Publicado: (2021)

The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: a retrospective observational study (IMPRESS)
por: Hudson, Mark, et al.
Publicado: (2017)

Application of a Mechanistic Model to Evaluate Putative Mechanisms of Tolvaptan Drug-Induced Liver Injury and Identify Patient Susceptibility Factors
por: Woodhead, Jeffrey L., et al.
Publicado: (2017)

CT With Hepatic Arterioportography as a Pretreatment Examination for Hepatocellular Carcinoma Patients: A Randomized Controlled Trial
por: Ohki, Takamasa, et al.
Publicado: (2013)

Deprescribing medications that may increase the risk of hepatic encephalopathy: A qualitative study of patients with cirrhosis and their doctors
por: Williams, Sydni, et al.
Publicado: (2021)

Routine screening of emergency admissions at risk of chronic hepatitis (SEARCH) identifies and links hepatitis B cases to care
por: Jacob, Rachael, et al.
Publicado: (2022)

Real-world evidence of long-term survival and healthcare resource use in patients with hepatic encephalopathy receiving rifaximin-α treatment: a retrospective observational extension study with long-term follow-up (IMPRESS II)
por: Aspinall, Richard J, et al.
Publicado: (2022)

Analysis of Notch and TGF-β Signaling Expression in Different Stages of Disease Progression During Hepatitis B Virus Infection
por: Trehanpati, Nirupama, et al.
Publicado: (2012)

Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus‐infected patients with renal impairment: results from a 7‐year, multicentre retrospective cohort study
por: Lampertico, Pietro, et al.
Publicado: (2020)

Very low probability of significant liver inflammation in chronic hepatitis B patients with low ALT levels in the absence of liver fibrosis
por: Sonneveld, Milan J., et al.
Publicado: (2020)

Interrelationships of Interferon and Immunity During Viral Infections
por: Glasgow, Lowell A.
Publicado: (1970)

The Defensive Role of the Interferon System
por: Baron, Samuel
Publicado: (1970)

Interferon and Ocular Viral Disease
por: Galin, Miles A., et al.
Publicado: (1970)

Interferon and Interferon Inducers in Protozoal Infections
por: Jahiel, Rene I.
Publicado: (1970)

Apolipoprotein CIII Overexpressing Mice Are Predisposed to Diet-Induced Hepatic Steatosis and Hepatic Insulin Resistance
por: Lee, Hui-Young, et al.
Publicado: (2011)

Response to the NCEPOD report: development of a care bundle for patients admitted with decompensated cirrhosis—the first 24 h
por: McPherson, Stuart, et al.
Publicado: (2016)

The impact of direct acting antivirals on hepatitis C virus disease burden and associated costs in four european countries
por: Mennini, Francesco S., et al.
Publicado: (2021)

Primary hepatic lymphoma mimicking acute hepatitis
por: Lee, Jeong-Ah, et al.
Publicado: (2013)

Role of Patatin-Like Phospholipase Domain-Containing 3 on Lipid-Induced Hepatic Steatosis and Insulin Resistance in Rats
por: Kumashiro, Naoki, et al.
Publicado: (2013)

Acute kidney injury is independently associated with death in patients with cirrhosis
por: Scott, Robert A, et al.
Publicado: (2013)

The Royal Free Hospital Score: A Calibrated Prognostic Model for Patients With Cirrhosis Admitted to Intensive Care Unit. Comparison With Current Models and CLIF-SOFA Score
por: Theocharidou, Eleni, et al.
Publicado: (2014)

Incidence, pattern and severity of abnormal liver blood tests among hospitalised patients with SARS-COV2 (COVID-19) in South Wales
por: Yeoman, Andrew, et al.
Publicado: (2020)

Activation of the c‐Jun N‐terminal kinase pathway aggravates proteotoxicity of hepatic mutant Z alpha1‐antitrypsin
por: Pastore, Nunzia, et al.
Publicado: (2017)

Hepatic amyloidosis
por: Shin, Yong Moon
Publicado: (2011)

Salford alcohol assertive outreach team: a new model for reducing alcohol-related admissions
por: Hughes, Neill R, et al.
Publicado: (2013)

Long‐term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia
por: Larrey, Dominique, et al.
Publicado: (2022)

Adult liver transplantation: UK clinical guideline - part 2: surgery and post-operation
por: Millson, Charles, et al.
Publicado: (2020)

Adult liver transplantation: A UK clinical guideline - part 1: pre-operation
por: Millson, Charles, et al.
Publicado: (2020)

Optimization of hepatitis C virus screening strategies by birth cohort in Italy
por: Kondili, Loreta A., et al.
Publicado: (2020)

Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver disease
por: Sangineto, Moris, et al.
Publicado: (2020)

Dissociation Between APOC3 Variants, Hepatic Triglyceride Content and Insulin Resistance
por: Kozlitina, Julia, et al.
Publicado: (2011)

Interaction between CHOP and FoxO6 promotes hepatic lipid accumulation
por: Kim, Dae Hyun, et al.
Publicado: (2020)

Risk of hepatic and extrahepatic cancer in NAFLD: A population‐based cohort study
por: Björkström, Karl, et al.
Publicado: (2022)

Are nucleos(t)ide analogues effective against severe outcomes in COVID-19 and hepatitis B virus coinfection?
por: Adali, Gupse, et al.
Publicado: (2021)

Metabolic regulation of hepatic PNPLA3 expression and severity of liver fibrosis in patients with NASH
por: Bruschi, Francesca V., et al.
Publicado: (2020)

Hepatitis C elimination in Sweden: Progress, challenges and opportunities for growth in the time of COVID‐19
por: Blach, Sarah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mag9d9oklpmudchv6m27p8v8dj